Definitions and practical differences among PDE, ADE and HBEL in pharmaceutical manufacturing and cleaning validation.
HBEL is the umbrella concept for health-based exposure limits. PDE and ADE are terms used in pharmaceutical regulatory and industry frameworks to express an acceptable daily exposure derived from toxicological and pharmacological evidence.
HBEL
Health-Based Exposure Limit is the broader descriptor of a health-based numerical exposure threshold.
PDE
Permitted Daily Exposure is widely used in ICH and regulatory guidance.
ADE
Acceptable Daily Exposure is common industry terminology, particularly in Risk-MaPP-related practice.
Practical interpretation
In cleaning and shared-facility programmes, the name is less important than the scientific basis, route, population, uncertainty and traceability of the derived value.
Frequently asked questions
Are PDE and ADE numerically always identical?
They are based on the same health-based concept, but the derivation and context must be reviewed rather than assumed.
Is HBEL a separate equation?
HBEL is the broader category of health-based limits rather than one single calculation.
Which term should a report use?
Use the terminology required by the applicable guidance and define it clearly.
Can an OEL be substituted for a PDE?
Not automatically; they protect different populations and exposure scenarios.
